These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29122439)

  • 1. Successful removal of porcine circovirus-1 from immunoglobulin G formulated in glycine solution using nanofiltration.
    Bao RM; Shibuya A; Uehira T; Sato T; Urayama T; Sakai K; Yunoki M
    Biologicals; 2018 Jan; 51():32-36. PubMed ID: 29122439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of porcine circovirus and porcine parvovirus from porcine-derived pepsin by low pH inactivation and cation exchange chromatography.
    Yang B; Wang H; Kaleas K; Butler M; Franklin J; Bill A; Baylis SA; Chen Q; Blümel J
    Biotechnol Prog; 2020 Jul; 36(4):e2968. PubMed ID: 31989781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine circovirus (PCV) removal by Q sepharose fast flow chromatography.
    Yang B; Wang H; Ho C; Lester P; Chen Q; Neske F; Baylis SA; Blümel J
    Biotechnol Prog; 2013; 29(6):1464-71. PubMed ID: 24039195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.
    Lackner C; Leydold SM; Modrof J; Farcet MR; Grillberger L; Schäfer B; Anderle H; Kreil TR
    Vaccine; 2014 Apr; 32(18):2056-61. PubMed ID: 24560672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of small non-enveloped viruses by nanofiltration.
    Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T
    Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration.
    Troccoli NM; McIver J; Losikoff A; Poiley J
    Biologicals; 1998 Dec; 26(4):321-9. PubMed ID: 10403036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
    Dubin G; Toussaint JF; Cassart JP; Howe B; Boyce D; Friedland L; Abu-Elyazeed R; Poncelet S; Han HH; Debrus S
    Hum Vaccin Immunother; 2013 Nov; 9(11):2398-408. PubMed ID: 24056737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.
    Yu Q; Liu Y; Du J; Liu Y; Zhang L; Guo T
    J Gen Virol; 2018 Jan; 99(1):103-108. PubMed ID: 29165219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of porcine circovirus contamination in human vaccines.
    Gilliland SM; Forrest L; Carre H; Jenkins A; Berry N; Martin J; Minor P; Schepelmann S
    Biologicals; 2012 Jul; 40(4):270-7. PubMed ID: 22402185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines.
    Ma H; Shaheduzzaman S; Willliams DK; Gao Y; Khan AS
    Vaccine; 2011 Oct; 29(46):8429-37. PubMed ID: 21835219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2.
    Hattermann K; Roedner C; Schmitt C; Finsterbusch T; Steinfeldt T; Mankertz A
    Xenotransplantation; 2004 May; 11(3):284-94. PubMed ID: 15099209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: enhanced nanofiltration and manufacturing process overview.
    Soluk L; Price H; Sinclair C; Atalla-Mikhail D; Genereux M
    Am J Ther; 2008; 15(5):435-43. PubMed ID: 18806519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanofiltration of plasma-derived biopharmaceutical products.
    Burnouf T; Radosevich M
    Haemophilia; 2003 Jan; 9(1):24-37. PubMed ID: 12558776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
    Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
    Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of a new type of porcine circovirus in swine (PCV): a type 1 and type 2 PCV recombinant.
    Gagnon CA; Music N; Fontaine G; Tremblay D; Harel J
    Vet Microbiol; 2010 Jul; 144(1-2):18-23. PubMed ID: 20097492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and analysis of porcine circovirus type 1 in Hungarian wild boars: short communication.
    Cságola A; Kiss I; Tuboly T
    Acta Vet Hung; 2008 Mar; 56(1):139-44. PubMed ID: 18401965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance.
    Parkkinen J; Rahola A; von Bonsdorff L; Tölö H; Törmä E
    Vox Sang; 2006 Feb; 90(2):97-104. PubMed ID: 16430667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of conventional polymerase chain reaction (PCR), with loop-mediated isothermal amplification and SYBR green I-based real-time PCR for the quantitation of porcine circovirus-1 DNA in contaminated samples destined for vaccine production.
    Yang BC; Wang FX; Zhang SQ; Song N; Li JX; Yang ZQ; Wen YJ; Wu H
    J Virol Methods; 2013 Jul; 191(1):1-8. PubMed ID: 23538038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.